Back to Search Start Over

Contactless magneto-permeabilization for intracellular plasmid DNA delivery in-vivo

Authors :
Dietmar P. Rabussay
Thomas J. Kardos
Source :
Human Vaccines & Immunotherapeutics. 8:1707-1713
Publication Year :
2012
Publisher :
Informa UK Limited, 2012.

Abstract

Electroporation, an attractive process for delivering DNA and other molecules into target cells in vivo and in vitro is limited by the necessity of electrodes that need to be in contact with the subject or object to be electroporated. We have used magnetic fields, which do not require material contact with the subject, to temporarily permeabilize cells in guinea pig skin in vivo to enhance uptake and expression of GFP plasmid DNA. The results show for the first time that magnetic fields can trigger a process likely similar to electroporation. In designing the magnetic pulses, our most important criterion was a high rate of change of the magnetic field, based on the principle described by Michael Faraday which is expressed by the formula: E = -dB/dt, (E, electric field, B, magnetic field, t, time). Magnetic fields were generated by a flat electromagnet in a hand-held applicator positioned above the target tissue. The magnetic pulses had a peak magnetic flux density of 4 tesla; 50 pulses were applied in 5 sec. Biphasic magnetic pulses were twice as effective as monophasic pulses and about equally effective as traditional electroporation pulses . Advantages of magnetopermeabilization over electoporation include: No contact between applicator and subject (“contact-less”); no need for invasive, disposable, sterile electrodes (“needle-less”); no pain from needles and reduced overall pain; no known side effects; easier and faster to administer than electroporation; less expensive due to absence of disposables; and, importantly, greater tissue penetration of the magnetic field allowing treatment of anatomical areas inaccessible by electroporation.

Details

ISSN :
2164554X and 21645515
Volume :
8
Database :
OpenAIRE
Journal :
Human Vaccines & Immunotherapeutics
Accession number :
edsair.doi.dedup.....87ca52f31e4acc9037c56af5d9b9d5b9
Full Text :
https://doi.org/10.4161/hv.21576